[Beta-interferon neutralizing antibodies. Do they have clinical value in patients with multiple sclerosis?].
Romero López
Jesús
J
Maciñeiras Montero
José Luis
JL
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000906:Antibodies / Q000097:blood*; D000917:Antibody Formation; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000276:immunology / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000906:Antibodies; D000068576:Interferon beta-1b; D016899:Interferon-beta